Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9994547
Heteroarylamide inhibitors of TBK1
granted -
US 9975903
Condensed heterocyclic compound
granted -
US 9969709
Guanidinobenzoic acid ester compound
granted -
US 9969705
Fused heterocyclic compound
granted -
US 9963443
Radiolabeled compounds
granted -
US 9957251
Heterocyclic compound
granted -
US 9944596
Heterocyclic compound
granted -
US 9944626
6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD
granted -
US 9932322
Method for producing sulfonyl chloride compound
granted -
US 9931340
Pyridazinone compounds and their use as DAAO inhibitors
granted -
US 9920047
Cyclopropanamine compound and use thereof
granted -
US 9907789
Sustained-release preparation
granted -
US 9901546
Orally disintegrable tablets
granted -
US 9890145
Heterocyclic compound
granted -
US 9884875
Heterocyclic compound and use thereof
granted -
US 9878989
Heterocyclic compound
granted -
US 9868725
Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease
granted -
US 9856310
UTI fusion proteins
granted -
US 9834520
Heterocyclic compound
granted -
US 9827255
Fumagillol derivatives
granted -
US 9828357
Cyclic compounds
granted -
US 9815938
Production method for poly(amino acid)
granted -
US 9809569
Process for producing heterocyclic compound
granted -
US 9801872
Pyridinyl and fused pyridinyl triazolone derivatives
granted